BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 1904040)

  • 1. [Androgens and other hormones in buserelin therapy].
    Fuchs U; Zwirner M
    Geburtshilfe Frauenheilkd; 1991 Feb; 51(2):140-2. PubMed ID: 1904040
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Hormonal changes in buserelin therapy].
    Fuchs U; Zwirner M
    Zentralbl Gynakol; 1989; 111(18):1236-40. PubMed ID: 2511705
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effect of the GnRH analog buserelin on sex hormone serum level in relation to treatment onset and duration].
    Urbancsek J; Rabe T; Gör U; Schulte B; Grunwald K; Papp Z; Runnebaum B
    Geburtshilfe Frauenheilkd; 1991 Aug; 51(8):617-25. PubMed ID: 1834511
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Treatment of endometriosis with the GnRH agonist buserelin (Suprecur): a multicenter study].
    Schindler AE; Bühler K; Mettler L; Fuchs U; Cirkel U; Ochs H; Schweppe KW; Koch R
    Geburtshilfe Frauenheilkd; 1994 Oct; 54(10):569-73. PubMed ID: 8001754
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sex steroid levels during treatment of endometriosis.
    Hirschowitz JS; Soler NG; Wortsman J
    Obstet Gynecol; 1979 Oct; 54(4):448-50. PubMed ID: 492624
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CA-125 monitored therapy with GnRH analogue of pelvic endometriosis.
    Negri P; Ricciardelli MA; Tomasi A; Grechi E; Fortini RM
    Acta Eur Fertil; 1992; 23(4):171-4. PubMed ID: 1343472
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of radical prostatectomy on serum hormone levels.
    Miller LR; Partin AW; Chan DW; Bruzek DJ; Dobs AS; Epstein JI; Walsh PC
    J Urol; 1998 Aug; 160(2):449-53. PubMed ID: 9679896
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of low-dose GnRH analogue (Buserelin) in the treatment of hirsutism.
    Bertoli A; Fusco A; Magnani A; Marini MA; Di Daniele N; Gatti S; Lauro R
    Exp Clin Endocrinol Diabetes; 1995; 103(1):15-20. PubMed ID: 7621099
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Ovarian suppression by the GnRH analog buserelin in the treatment of endometriosis. Clinical, biochemical and pelviscopic studies].
    Raitz von Frentz M; Schweppe KW
    Geburtshilfe Frauenheilkd; 1990 Aug; 50(8):634-9. PubMed ID: 2145192
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of LHRH agonist (buserelin) on pulsatile secretion of LHRH and LH.
    Okuda K; Ushiroyama T; Yoshikawa M; Sugimoto O
    Nihon Sanka Fujinka Gakkai Zasshi; 1988 Dec; 40(12):1889-93. PubMed ID: 3145318
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Initial results in the treatment of endometriosis with the LH-RH analog buserelin].
    Hardt W; Schmidt-Gollwitzer M; Schmidt-Gollwitzer K; Genz T; Nevinny-Stickel J
    Geburtshilfe Frauenheilkd; 1986 Aug; 46(8):483-9. PubMed ID: 3093311
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Obesity and endocrine functions. Sex hormones].
    Kley HK; Zimmermann H; Krüskemper G
    Dtsch Med Wochenschr; 1981 Sep; 106(37):1163-7. PubMed ID: 6806057
    [No Abstract]   [Full Text] [Related]  

  • 13. Clinical study on finding optimal dose of a potent LHRH agonist (buserelin) for the treatment of endometriosis--multicenter trial in Japan.
    Minaguchi H; Uemura T; Shirasu K
    Prog Clin Biol Res; 1986; 225():211-25. PubMed ID: 3097667
    [No Abstract]   [Full Text] [Related]  

  • 14. Pituitary-testicular function of prostatic cancer patients during treatment with a gonadotropin-releasing hormone agonist analog. I. Circulating hormone levels.
    Huhtaniemi I; Nikula H; Rannikko S
    J Androl; 1987; 8(6):355-62. PubMed ID: 3123445
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma endothelin and LH-RH, LH, FSH, prolactin, progesterone, 17alpha-hydroxyprogesterone, estrone, 17beta-estradiol, delta4-androstenedione, testosterone, active renin, angiotensin-II and ANP levels in blood and LH, estrone and 17beta-estradiol and pregnanediol levels in urine of normal cycling women.
    Usuki S; Kondoh K; Kubo T
    J Cardiovasc Pharmacol; 2000 Nov; 36(5 Suppl 1):S421-7. PubMed ID: 11078439
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes with age in levels of serum gonadotropins, prolactin and gonadal steroids in prepubertal male and female rats.
    Döhler KD; Wuttke W
    Endocrinology; 1975 Oct; 97(4):898-907. PubMed ID: 1193012
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sex hormone status in women suffering from rheumatoid arthritis.
    Cutolo M; Balleari E; Giusti M; Monachesi M; Accardo S
    J Rheumatol; 1986 Dec; 13(6):1019-23. PubMed ID: 3104587
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Behavior of LH, FSH, total testosterone, free testosterone and SHBG serum levels in the therapy of prostatic cancer with Turisteron (ethinyl estradiol sulfonate)].
    Guddat HM; Schnorr D; Dörner G; Stahl F; Rohde W
    Z Urol Nephrol; 1987 Dec; 80(12):665-8. PubMed ID: 3126615
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of intranasal or subcutaneous luteinizing hormone-releasing hormone agonist inhibition of ovarian function in the treatment of endometriosis.
    Lemay A; Maheux R; Huot C; Blanchet J; Faure N
    Am J Obstet Gynecol; 1988 Feb; 158(2):233-6. PubMed ID: 3124618
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Basal prolactin and the behaviour of the gonadotrophins, testosterone, androstenedione, estradiol, and the sex-hormone-binding globulin during stimulation with clomiphene in subjects with spermatogenic disorders.
    Bolufer P; Rodriguez A; Antonio P; Bosch E; Peiró T
    Exp Clin Endocrinol; 1985 Dec; 86(2):197-206. PubMed ID: 3937739
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.